OSG — Octave Specialty Balance Sheet
0.000.00%
- $230.15m
- $690.40m
- $236.90m
- 23
- 81
- 46
- 50
Annual balance sheet for Octave Specialty, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | C2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Net Total Receivables | — | — | — | 55.4 | 86.5 |
| Net Property, Plant And Equipment | 23 | 21 | 19 | 18.1 | 9.19 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Insurance Receivables | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Deferred Policy Acquisition Costs | |||||
| Total Other Assets | |||||
| Total Assets | 12,303 | 7,973 | 8,428 | 8,058 | 2,223 |
| Accrued Expenses | |||||
| Policy Liabilities | |||||
| Notes Payable / Short Term Debt | |||||
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 11,265 | 6,722 | 7,067 | 7,260 | 1,508 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 1,038 | 1,251 | 1,361 | 798 | 716 |
| Total Liabilities & Shareholders' Equity | 12,303 | 7,973 | 8,428 | 8,058 | 2,223 |
| Total Common Shares Outstanding |